| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.91B | 5.06B | 4.67B | 5.02B | 6.07B | 5.38B |
| Gross Profit | 390.80M | 383.99M | 423.59M | 473.12M | 755.74M | 846.04M |
| EBITDA | 466.00M | 507.62M | 463.09M | 521.11M | 812.03M | 991.25M |
| Net Income | 140.06M | 167.60M | 167.12M | 268.57M | 572.68M | 721.49M |
Balance Sheet | ||||||
| Total Assets | 5.62B | 5.31B | 5.57B | 5.53B | 5.94B | 5.21B |
| Cash, Cash Equivalents and Short-Term Investments | 473.69M | 666.51M | 894.94M | 1.35B | 1.59B | 957.48M |
| Total Debt | 1.45B | 1.35B | 1.49B | 1.48B | 1.62B | 812.03M |
| Total Liabilities | 2.71B | 2.43B | 2.60B | 2.44B | 2.51B | 1.86B |
| Stockholders Equity | 2.91B | 2.88B | 2.95B | 3.07B | 3.42B | 3.34B |
Cash Flow | ||||||
| Free Cash Flow | -103.78M | 89.64M | -327.75M | 305.29M | 444.07M | 532.30M |
| Operating Cash Flow | 201.60M | 384.05M | 540.85M | 808.51M | 605.64M | 648.68M |
| Investing Cash Flow | -389.12M | -254.57M | -666.51M | -616.52M | -191.99M | 138.27M |
| Financing Cash Flow | -4.41M | -363.50M | -162.02M | -555.47M | 171.08M | -730.38M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | HK$837.50M | 7.09 | 19.46% | 8.89% | -8.00% | -11.37% | |
67 Neutral | HK$2.51B | 4.54 | 8.52% | 4.00% | 3.40% | 151.24% | |
63 Neutral | HK$2.32B | 1.52 | 14.74% | 12.14% | -0.95% | 2.58% | |
63 Neutral | HK$1.76B | 2.63 | 12.81% | 7.98% | 13.52% | 4.95% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | HK$1.55B | 6.53 | 4.73% | 8.06% | -2.44% | -5.98% | |
46 Neutral | HK$857.52M | 10.31 | 1.70% | 1.90% | -7.20% | -55.24% |